A randomized controlled trial of continuous positive airway pressure on glucose tolerance in obese patients with obstructive sleep apnea

Sleep

Volumn 39, Issue 1, 2016, Pages 35-41

  Salord, Neus ^a,b,c,d   Fortuna, Ana Maria ^c,d,e   Monasterio, Carmen ^a,b,d   Gasa, Mercè ^a,b   Pérez, Antonio ^c,f   Bonsignore, Maria R ^g   Vilarrasa, Núria ^a,f   Montserrat, Josep Maria ^d,h   Mayos, Mercedes ^c,d,e  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g UNIVERSITY OF PALERMO   (Italy)

^h HOSPITAL CLÍNIC   (Spain)

Author keywords

Continuous positive airway pressure; Glucose tolerance; Insulin resistance; Obstructive sleep apnea

Indexed keywords

ADULT; ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CPAP DEVICE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDERED BREATHING; THERAPY EFFECT; WEIGHT REDUCTION; ANALYSIS; COMPLICATION; GLUCOSE INTOLERANCE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SLEEP APNEA, OBSTRUCTIVE;

GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; BLOOD GLUCOSE; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; WEIGHT LOSS;

EID: 84957090330     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.5312     Document Type: Article

References (30)

1. Bonsignore MR, McNicholas WT, Montserrat JM, Eckel J. Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J 2012;39:746-67.
2. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-45.
3. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005;28:1769-78.
4. Ho JS, Cannaday JJ, Barlow CE, Mitchell TL, Cooper KH, FitzGerald SJ. Relation of the number of metabolic syndrome risk factors with allcause and cardiovascular mortality. Am J Cardiol 2008;102:689-92.
5. Lam JC, Mak JC, Ip MS. Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology 2012;17:223-36.
6. Lévy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009;34:243-60.
7. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: A population-based study. Am J Respir Crit Care Med 2005;172:1590-5.
8. Gasa M, Salord N, Fortuna AM, et al. Obstructive sleep apnoea and metabolic impairment in severe obesity. Eur Respir J 2011;38:1089-97.
9. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010;7:677-85.
10. Sanders MH, Montserrat JM, Farré R, Givelber RJ. Positive pressure therapy: A perspective on evidence-based outcomes and methods of application. Proc Am Thorac Soc 2008;5:161-72.
11. Harsch IA, Schahin SP, Radespiel-Tröger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-62.
12. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007;29:720-27.
13. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007;62:969-74.
14. Hoyos CM, Killick R, Yee BJ, Phillips CL, Grunstein RR, Liu PY. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: A randomised sham-controlled study. Thorax 2012;67:1081-9.
15. Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 2012;35:617-25.
16. Pépin JL, Tamisier R, Lévy P. Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective. Thorax 2012;67:1025-7.
17. Craig CL, Marchall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-95.
18. Marin R, de la Sierra A, Armario P, Campo C, Banegas JR, Gorostidi M, Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). 2005 Spanish guidelines in diagnosis and treatment of arterial hypertension. Med Clin (Barc) 2005;125:24-34.
19. Masa JF, Jiménez A, Durán J, et al. Alternative methods of titrating continuous positive airway pressure: A large multicenter study. Am J Respir Crit Care Med 2004;170:1218-24.
20. Genuth S, Alberti KG, Bennett P, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9.
22. Lam JC, Lam B, Yao TJ, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J 2010;35:138-45.
23. Comondore VR, Cheema R, Fox J, et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: A pilot feasibility randomized crossover trial. Lung 2009;187:17-22.
24. Iftikhar IH, Khan MF, Das A, Magalang UJ. Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes. Ann Am Thorac Soc 2013;10:115-20.
25. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycemia: The current status on definition and intervention. Diabetic Med 2002;19:708-23.
26. Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006;29:1909-4.
27. Ten-year follow-up report on Birmingham Diabetes Survey of 1961. Report by the Birmingham Diabetes Survey Working Party. Br Med J 1976;2:35-7.
28. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-9.
29. Hoyos CM, Sullivan DR, Liu PY. Effect of CPAP on the metabolic syndrome: A randomized sham-controlled study. Thorax 2013;68:588-9.
30. Bonsignore MR, Borel AL, Machan E, Grunstein R. Sleep apnoea and metabolic dysfunction. Eur Respir Rev 2013;22:353-64.